Pharsight

Photofrin patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5438071 PINNACLE BIOLGS Stable porfimer sodium compositions and methods for their manufacture
Aug, 2012

(11 years ago)

Photofrin is owned by Pinnacle Biolgs.

Photofrin contains Porfimer Sodium.

Photofrin has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Photofrin are:

  • US5438071

Photofrin was authorised for market use on 27 December, 1995.

Photofrin is available in injectable;injection dosage forms.

The generics of Photofrin are possible to be released after 01 August, 2012.

Drugs and Companies using PORFIMER SODIUM ingredient

Market Authorisation Date: 27 December, 1995

Treatment: NA

Dosage: INJECTABLE;INJECTION

More Information on Dosage

PHOTOFRIN family patents

Family Patents